Molecular Biology Laboratory, Pathology Divison, Multidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), CONICET-GCBA, Hospital de Niños R. Gutiérrez, Gallo 1330, C1425EFD, Buenos Aires, Argentina.
Pathology Division, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina.
Cancer Immunol Immunother. 2021 Jun;70(6):1519-1526. doi: 10.1007/s00262-020-02787-2. Epub 2020 Nov 12.
Classic Hodgkin lymphoma (cHL) is a lymphoid malignancy in which the microenvironment, where the neoplastic cells are immersed, contributes to the lymphomagenesis process. Epstein-Barr virus (EBV) presence also influences cHL microenvironment composition and contributes to pathogenesis. An increase in PDL1 expression in tumor cells and at the microenvironment was demonstrated in adult cHL. Therefore, our aim was to assess PD1/PDL1 pathway and EBV influence on this pathway in pediatric cHL, given that in Argentina, our group proved a higher incidence of EBV-associated pediatric lymphoma in children.
For that purpose, EBV presence was assessed by in situ hybridization, whereas PD1 and PDL1 expressions were studied by immunohistochemistry. PDL1 genetic alterations were analyzed by FISH, and survival was evaluated for PD1 and PDL1 expressions.
EBV presence demonstrated no influence neither on PD1 expression at the microenvironment nor on PDL1 expression at HRS tumor cells. Unexpectedly, only 38% pediatric cHL displayed PDL1 genetic alterations by FISH, and no difference was observed regarding EBV presence. However, in EBV-related cHL cases, a higher number of PDL1 + cells were detected at the microenvironment.
Even though a high cytotoxic environment was previously described in EBV-related pediatric cHL, it might be counterbalanced by an immunoregulatory micro-environmental PDL1 + niche. This regulation may render a cytotoxic milieu that unsuccessfully try to eliminate EBV + Hodgkin Reed Sternberg tumor cells in pediatric patients.
经典霍奇金淋巴瘤(cHL)是一种淋巴恶性肿瘤,其中肿瘤细胞所处的微环境有助于淋巴瘤的发生过程。EB 病毒(EBV)的存在也会影响 cHL 微环境的组成,并促进发病机制。在成人 cHL 中已经证明肿瘤细胞和微环境中 PDL1 表达增加。因此,我们的目的是评估 PD1/PDL1 通路以及 EBV 对儿科 cHL 中该通路的影响,因为在阿根廷,我们的研究小组证明了 EBV 相关儿科淋巴瘤在儿童中的发病率更高。
为此,通过原位杂交评估 EBV 的存在,通过免疫组织化学研究 PD1 和 PDL1 的表达。通过 FISH 分析 PDL1 基因改变,并评估 PD1 和 PDL1 表达的生存情况。
EBV 的存在既不影响微环境中 PD1 的表达,也不影响 HRS 肿瘤细胞中 PDL1 的表达。出乎意料的是,只有 38%的儿科 cHL 通过 FISH 显示 PDL1 基因改变,且与 EBV 的存在无关。然而,在 EBV 相关的 cHL 病例中,在微环境中检测到更多的 PDL1+细胞。
尽管之前在 EBV 相关的儿科 cHL 中描述了高细胞毒性环境,但它可能被免疫调节性 PDL1+微环境所平衡。这种调节可能会产生一种细胞毒性环境,无法成功消除儿科患者中 EBV+霍奇金氏 Reed-Sternberg 肿瘤细胞。